Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - atracurium besilate, quantity: 25 mg - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besilate is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - atracurium besilate, quantity: 50 mg - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besilate is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - atracurium besilate, quantity: 25 mg - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besilate is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - atracurium besilate, quantity: 50 mg - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besilate is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - atracurium besilate - solution for injection - 10mg/1ml